Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as Rho kinase inhibitors
Details for Australian Patent Application No. 2009262509 (hide)
International Classifications
Event Publications
20 January 2011 PCT application entered the National Phase
PCT publication WO2009/156092 Priority application(s): WO2009/156092
21 April 2011 Amendment Made
The nature of the amendment is: Amend the priority details to read 08290607.4 24 Jun 2008 EP 2009262516 Sanofi-Aventis The nature of the amendment is: Amend the priority details to read 08290605.8 24 Jun 2008 EP 2009262517 Sanofi-Aventis The nature of the amendment is: Amend the priority details to read 08290606.6 24 Jun 2008 EP 2009262878 KCI Licensing, Inc. The nature of the amendment is: Amend the name of the inventor to read Johnson, Royce W.; Wilkes, Robert Peyton; Long, Justin Alexander and Kazala Jr.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009262515-Thiadiazolyloxyphenylamidines and use thereof as fungicides
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser